Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 232

Similar articles for PubMed (Select 23934169)

1.

Six percent hydroxyethyl starch 130/0.4 (Voluven®) versus 5% human serum albumin for volume replacement therapy during elective open-heart surgery in pediatric patients.

Van der Linden P, De Villé A, Hofer A, Heschl M, Gombotz H.

Anesthesiology. 2013 Dec;119(6):1296-309. doi: 10.1097/ALN.0b013e3182a6b387.

PMID:
23934169
2.

HES 130/0.4 (Voluven) or human albumin in children younger than 2 yr undergoing non-cardiac surgery. A prospective, randomized, open label, multicentre trial.

Standl T, Lochbuehler H, Galli C, Reich A, Dietrich G, Hagemann H.

Eur J Anaesthesiol. 2008 Jun;25(6):437-45. doi: 10.1017/S0265021508003888. Epub 2008 Mar 13.

PMID:
18339212
3.

Volume therapy in the critically ill: is there a difference?

Boldt J, Müller M, Mentges D, Papsdorf M, Hempelmann G.

Intensive Care Med. 1998 Jan;24(1):28-36. Retraction in: Intensive Care Med. 2014 Jan;40(1):145.

PMID:
9503219
4.

Hydroxyethyl starch reduces coagulation competence and increases blood loss during major surgery: results from a randomized controlled trial.

Rasmussen KC, Johansson PI, Højskov M, Kridina I, Kistorp T, Thind P, Nielsen HB, Ruhnau B, Pedersen T, Secher NH.

Ann Surg. 2014 Feb;259(2):249-54. doi: 10.1097/SLA.0000000000000267.

PMID:
24100337
5.

Volume replacement therapy during major orthopedic surgery using Voluven (hydroxyethyl starch 130/0.4) or hetastarch.

Gandhi SD, Weiskopf RB, Jungheinrich C, Koorn R, Miller D, Shangraw RE, Prough DS, Baus D, Bepperling F, Warltier DC.

Anesthesiology. 2007 Jun;106(6):1120-7.

PMID:
17525586
6.

Safety of HES 130/0.4 (Voluven(R)) in patients with preoperative renal dysfunction undergoing abdominal aortic surgery: a prospective, randomized, controlled, parallel-group multicentre trial.

Godet G, Lehot JJ, Janvier G, Steib A, De Castro V, Coriat P.

Eur J Anaesthesiol. 2008 Dec;25(12):986-94. doi: 10.1017/S026502150800447X. Epub 2008 May 20. Erratum in: Eur J Anaesthesiol. 2008 Dec;25(12):1042.

PMID:
18492315
7.

A novel hydroxyethyl starch (Voluven) for effective perioperative plasma volume substitution in cardiac surgery.

Gallandat Huet RC, Siemons AW, Baus D, van Rooyen-Butijn WT, Haagenaars JA, van Oeveren W, Bepperling F.

Can J Anaesth. 2000 Dec;47(12):1207-15.

PMID:
11132743
8.

Stroke volume optimization after anaesthetic induction: An open randomized controlled trial comparing 0.9% NaCl versus 6% hydroxyethyl starch 130/0.4.

L'Hermite J, Muller L, Cuvillon P, Bousquet PJ, Lefrant JY, de La Coussaye JE, Ripart J.

Ann Fr Anesth Reanim. 2013 Oct;32(10):e121-7. doi: 10.1016/j.annfar.2013.05.006. Epub 2013 Jul 15.

PMID:
23867539
9.
10.

Perioperative volume replacement in children undergoing cardiac surgery: albumin versus hydroxyethyl starch 130/0.4.

Hanart C, Khalife M, De Villé A, Otte F, De Hert S, Van der Linden P.

Crit Care Med. 2009 Feb;37(2):696-701. doi: 10.1097/CCM.0b013e3181958c81.

PMID:
19114887
11.

The effect of 6% hydroxyethyl starch 130/0.4 on renal function, arterial blood pressure, and vasoactive hormones during radical prostatectomy: a randomized controlled trial.

Kancir AS, Johansen JK, Ekeloef NP, Pedersen EB.

Anesth Analg. 2015 Mar;120(3):608-18. doi: 10.1213/ANE.0000000000000596.

PMID:
25627076
12.

Efficacy and safety of hydroxyethyl starch 6% 130/0.4 in a balanced electrolyte solution (Volulyte) during cardiac surgery.

Base EM, Standl T, Lassnigg A, Skhirtladze K, Jungheinrich C, Gayko D, Hiesmayr M.

J Cardiothorac Vasc Anesth. 2011 Jun;25(3):407-14. doi: 10.1053/j.jvca.2010.12.005. Epub 2011 Feb 22.

PMID:
21345699
13.

Cardiopulmonary bypass priming using a high dose of a balanced hydroxyethyl starch versus an albumin-based priming strategy.

Boldt J, Suttner S, Brosch C, Lehmann A, Röhm K, Mengistu A.

Anesth Analg. 2009 Dec;109(6):1752-62. doi: 10.1213/ANE.0b013e3181b5a24b. Retraction in: Shafer SL. Anesth Analg. 2010 Dec;111(6):1567.

PMID:
19923501
15.
16.

Hydroxyethyl starch 130/0.42/6:1 for perioperative plasma volume replacement in 1130 children: results of an European prospective multicenter observational postauthorization safety study (PASS).

Sümpelmann R, Kretz FJ, Luntzer R, de Leeuw TG, Mixa V, Gäbler R, Eich C, Hollmann MW, Osthaus WA.

Paediatr Anaesth. 2012 Apr;22(4):371-8. doi: 10.1111/j.1460-9592.2011.03776.x. Epub 2011 Dec 23.

PMID:
22211931
17.

Crystalloids vs. colloids: KO at the twelfth round?

Phillips DP, Kaynar AM, Kellum JA, Gomez H.

Crit Care. 2013 May 29;17(3):319. doi: 10.1186/cc12708.

18.

Hydroxyethyl starch 130/0.4 versus modified fluid gelatin for volume expansion in cardiac surgery patients: the effects on perioperative bleeding and transfusion needs.

Van der Linden PJ, De Hert SG, Deraedt D, Cromheecke S, De Decker K, De Paep R, Rodrigus I, Daper A, Trenchant A.

Anesth Analg. 2005 Sep;101(3):629-34, table of contents.

PMID:
16115963
19.

Resuscitation with hydroxyethyl starch improves renal function and lactate clearance in penetrating trauma in a randomized controlled study: the FIRST trial (Fluids in Resuscitation of Severe Trauma).

James MF, Michell WL, Joubert IA, Nicol AJ, Navsaria PH, Gillespie RS.

Br J Anaesth. 2011 Nov;107(5):693-702. doi: 10.1093/bja/aer229. Epub 2011 Aug 19.

20.

Volume replacement with a balanced hydroxyethyl starch (HES) preparation in cardiac surgery patients.

Boldt J, Mayer J, Brosch C, Lehmann A, Mengistu A.

J Cardiothorac Vasc Anesth. 2010 Jun;24(3):399-407. doi: 10.1053/j.jvca.2010.03.001. Retraction in: J Cardiothorac Vasc Anesth. 2011 Aug;25(4):755-7.

PMID:
20510247
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk